P3 Health Partners Inc. (PIII)
NASDAQ: PIII · IEX Real-Time Price · USD
0.485
-0.005 (-0.98%)
At close: Jul 2, 2024, 4:00 PM
0.509
+0.024 (4.99%)
After-hours: Jul 2, 2024, 7:29 PM EDT
Company Description
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States.
It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.
P3 Health Partners Inc.
| Country | United States |
| Founded | 2015 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 400 |
| CEO | Dr. Aric Coffman M.D. |
Contact Details
Address: 2045 W Grand Ave Ste B, Pmb # 82152 Chicago, Illinois 60612-1577 United States | |
| Phone | 312-822-8897 |
| Website | p3hp.org |
Stock Details
| Ticker Symbol | PIII |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001832511 |
| CUSIP Number | 744413105 |
| ISIN Number | US7444131053 |
| Employer ID | 85-2992794 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Dr. Sherif Abdou F.A.C.E.P., FACP, M.D. | Co-Founder, Chief Executive Officer and Director |
| Dr. Amir Bacchus M.B.A., M.D. | Co-Founder, Chief Medical Officer and Director |
| Atul Kavthekar | Chief Financial Officer and Chief Accounting Officer |
| William Bettermann | Executive Vice President and Chief Operating Officer |
| Devery Goodey | Senior Vice President of Technology |
| Roy Youngblood | Director of Compliance |
| Leslie Fisher | Senior Vice President of Legal Affairs and General Counsel |
| Kassi Belz APR | Executive Vice President of Communications, Culture and Engagement |
| Todd Lefkowitz MHA | Chief Managed Care Officer |
| Sarah Bussmann B.S.N., CRNI, M.H.A., R.N. | Chief of Staff |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 28, 2024 | 424B3 | Prospectus |
| Jun 27, 2024 | EFFECT | Notice of Effectiveness |
| Jun 26, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Jun 18, 2024 | S-3 | Registration statement under Securities Act of 1933 |
| Jun 7, 2024 | 8-K | Current Report |
| May 24, 2024 | 8-K | Current Report |
| May 23, 2024 | 8-K | Current Report |
| May 20, 2024 | 8-K | Current Report |
| May 9, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| May 9, 2024 | 8-K | Current Report |